Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1441.70
10.05 (0.70%)
< Home < Back

Cipla’s arm enters into collaboration with Teva

Date: 09-10-2014

Cipla’s step-down subsidiary - Medpro Pharmaceutica has entered into collaboration with Teva Pharmaceuticals, an affiliate of Teva Pharmaceutical Industries (Teva) - the largest generic pharmaceutical manufacturer in the world with a presence in about 60 countries and approximately 45,000 dedicated employees worldwide. Medpro Pharmaceutica is a subsidiary company of Cipla Medpro, the third largest pharmaceutical company in South Africa.

The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva’s broad pharmaceutical product portfolio in South Africa. The collaboration is restricted to the territory of South Africa and is subjected to approval by the Competition Commission of South Africa.

The collaboration with Teva in South Africa will focus on the following therapeutic areas: oncology, central nervous system, women's health, cardiovascular, ophthalmology and other specialty products.